HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intimate Brands buyout

This article was originally published in The Rose Sheet

Executive Summary

Intimate Brands to begin merging into a subsidiary of The Limited March 21 after close of trading, company announces March 21. Move comes after 72.6 mil. IBI shares were tendered to The Limited as part of the company's stock repurchase offer, giving The Limited a 98% stake in Intimate Brands. The Limited announced the buy-back plan Feb. 5, but later sweetened its offer after several IBI shareholders filed lawsuits alleging the terms undervalued the company. An outside review panel appointed by IBI recommended shareholders accept the stock swap, which is valued at $1.56 bil. (1"The Rose Sheet" March 18, 2002, p. 4)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel